Literature DB >> 15090751

Clinical implications of the allergic rhinitis-asthma link.

Thomas B Casale1, Mark S Dykewicz.   

Abstract

A possible link between allergic rhinitis (AR) and allergic asthma has long been a subject of debate. Surveys report that up to 78% of asthma patients have AR and 38% of patients with AR have asthma. Evidence points to a causal or coincidental relation between these upper and lower airway diseases. Various agents used to manage one entity have shown benefit in treating the other. The 2001 Allergic Rhinitis and Its Impact on Asthma guidelines call for patients with either condition to be assessed for the other. Medical therapy for AR or asthma should be chosen with awareness of the probable coexistence of these diseases. We present the case for and against the united airway theory proposed to explain the association between these diseases. The roles of various therapies for dually afflicted patients are evaluated, including topical corticosteroids, antihistamines, leukotriene modifiers, anti-immunoglobulin E monoclonal antibody, theophylline, and immunotherapy.

Entities:  

Mesh:

Year:  2004        PMID: 15090751     DOI: 10.1097/00000441-200403000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  11 in total

1.  Therapeutic effect of Biyuan tongqiao granules combined with mometasone furoate nasal spray on clinical symptoms of children with allergic rhinitis.

Authors:  Zan Ding; Nana Yang; Xin Cui
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Exploring the Asthma Network in People with Allergic Rhinitis Utilizing an Egocentric Social Network Analysis.

Authors:  Biljana Cvetkovski; Rachel Tan; Vicky Kritikos; Kwok Yan; Elizabeth Azzi; Pamela Srour; Sinthia Bosnic-Anticevich
Journal:  Pulm Ther       Date:  2019-07-12

3.  The effectiveness and safety of sanfu acupoint herbal patching for treating allergic rhinitis: A protocol for systematic review and meta-analysis.

Authors:  Qiaochu Zhu; Zhongyu Zhou; Dan Wei; Yang Jiao; Yangpu Zhang; Xiaohui Tian; Yan Wang; Fu Dong; Aiqun Song
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

4.  MicroRNA-182-5p relieves murine allergic rhinitis via TLR4/NF-κB pathway.

Authors:  Aichun Zhang; Yangzi Jin
Journal:  Open Med (Wars)       Date:  2020-12-24

5.  Lidocaine relieves murine allergic rhinitis by regulating the NF-κB and p38 MAPK pathways.

Authors:  Jing Xiang; Zhen Yang; Qiang Zhou
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

6.  The effectiveness and safety of acupuncture for allergic rhinitis: Protocol for an overview of systematic reviews and meta-analyses.

Authors:  Jun Yang; Jun Xiong; Xue Wang; Ting Yuan; Yong Fu; Yunfeng Jiang; Xiaohong Zhou; Kai Liao; Lingling Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

7.  C‑C chemokine receptor type 3 gene knockout alleviates inflammatory responses in allergic rhinitis model mice by regulating the expression of eosinophil granule proteins and immune factors.

Authors:  Xinhua Zhu; Ke Liu; Jialin Wang; Haisen Peng; Qibin Pan; Shuhong Wu; Yinli Jiang; Yuehui Liu
Journal:  Mol Med Rep       Date:  2018-08-10       Impact factor: 2.952

8.  Association between Allergic Rhinitis and Regular Physical Activity in Adults: A Nationwide Cross-Sectional Study.

Authors:  Jewel Park; Joo Hee Park; Jaehyung Park; Jimi Choi; Tae Hoon Kim
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

Review 9.  Biological Properties and the Role of IL-25 in Disease Pathogenesis.

Authors:  Yuwan Liu; Zewei Shao; Guoqiang Shangguan; Qingli Bie; Bin Zhang
Journal:  J Immunol Res       Date:  2018-09-23       Impact factor: 4.818

10.  Heat-sensitive moxibustion for anaphylactic rhinitis: A protocol of systematic review and meta-analysis of randomized clinical trials.

Authors:  Jun Xiong; Jun Yang; Ting Yuan; Xue Wang; Yunfeng Jiang; Xiaohong Zhou; Kai Liao; Lingling Xu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.